Genenta Science
SAEN
4 hedge funds and large institutions have $1.42M invested in Genenta Science in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
466% more capital inflows, than outflows
Capital inflows: $57.1K | Capital outflows: $10.1K
0.04% more ownership
Funds ownership: 1.93% → 1.97% (+0.04%)
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$57.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$7.95K |
| 2 |
Morgan Stanley
New York
|
-$2.14K |
SAEN Hedge Fund Activity: Q4 2024 in Review
4 of the 7,622 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (SAEN) for Q4 2024, worth a combined $1.42M — down 3.5% from $1.48M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of SAEN and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $57.1K. The largest seller was UBS Group, exiting entirely with an estimated $7.95K sold.
- 4 institutional investors held Genenta Science (SAEN) as of Q4 2024, down from 5 in Q3 2024.
- Funds reported $1.42M of Genenta Science stock for Q4 2024, down 3.5% quarter-over-quarter.
- 1 fund opened new Genenta Science positions in Q4 2024 and 2 closed out, a net change of -1 holder.
- The largest Genenta Science buyer in Q4 2024 was Citadel Advisors, an estimated $57.1K added.
- The largest Genenta Science seller in Q4 2024 was UBS Group, an estimated $7.95K sold.
Based on aggregated 13F filings for Q4 2024.